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Zusammenfassung 
 
Die Auswirkung der Verabreichung von Metoclopramid (MC) auf den 
Serumprolaktinspiegel (PRL), den Laktosegehalt (LM) sowie die Bruttoenergie (BE) 
und Trockenmasse der Milch (TM)  wurde an 20 gesunden Zuchthündinnen 
verschiedener Rassen in der Frühlaktation untersucht. LM in der Milch und die 
Gewichtszunahme der 121 Welpen wurden bestimmt um die Wirkung auf die 
Milchproduktion abzuschätzen. Zehn Hunde erhielten 6 Tage (T-Gruppe) MC (0,2 
mg / kg per os qid), beginnend 10-24 Stunden nach der Geburt des letzten Welpen 
(Tag 0). Zehn Hündinnen dienten als Kontrollen (C-Gruppe). Blut- und Milchproben 
wurden bei den Hündinnen am Tag 0,1,2,4 und 6 gesammelt. Die Milchproben von 
Tag 1 und 2 sowie von Tag 4 und 6 wurden aufgrund des geringen Volumens 
gepoolt. Die Welpen wurden zweimal täglich gewogen. PRL stieg in beiden Gruppen 
über die Zeit deutlich an. Mittels Kontrastanalyse zeigte sich ein PRL-Anstieg von 
Tag 0 auf Tag 1 in der T- (P = 0,050), nicht aber in der C-Gruppe. LM nahm über die 
Studienzeit deutlich zu und war in der T-Gruppe höher als in der C-Gruppe. Die TM 
war unverändert, während sich der Zeitverlauf der BE zwischen C- und T- Hunden 
unterschied (P = 0,006). Die Gewichtszunahme der Welpen beider Gruppen war 
vergleichbar. Bei gesunden Hündinnen induzierte die orale Anwendung von MC post 
partum eine transiente PRL-Zunahme und stimulierte die Milchlaktoseproduktion. 
Hunde mit unzureichender oder verzögerter Milchproduktion könnten von dieser 
Behandlung profitieren. 
 
 
Prolaktin, Metoclopramid, Laktosegehalt, Milchmenge 
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Summary 
 
Twenty client-owned, healthy breeding bitches of various breeds and their 121 pups 
were used to study the effect of oral metoclopramide (MC) on serum prolactin (PRL) 
levels, on milk lactose, gross energy and dry matter during early lactation. Milk 
lactose and puppy weight gain were determined to estimate treatment effect on milk 
production. Ten dogs received MC (0.2 mg/kg [0.09 mg/lb], per os, every 6 hours) for 
6 days (T group) starting 10-24 hours after the birth of the last puppy (Day 0). Ten 
bitches served as controls (C group). Blood and milk samples from all bitches were 
collected on Day 0,1,2,4 and 6. Milk samples on Day 1 and 2, and on Day 4 and 6 
were pooled due to small volume. Puppies were weighed twice daily. Serum PRL 
increased significantly over time in both groups, and no treatment effect was seen. 
When the day-to-day change was analysed with contrasts, PRL increased from Day 
0 to Day 1 in the T (P = 0.050) but not in the C group. Milk lactose increased 
significantly during the study period and was higher in the T than in the C group. Milk 
dry matter was unchanged, while the time course of milk gross energy differed 
between treated and control dogs (P =0.006). Puppy weight gain was not affected by 
MC treatment. In healthy bitches, the oral application of MC after parturition induced 
a transient serum PRL increase and stimulated milk lactose production. Especially 
dogs with insufficient or delayed milk production could benefit from this treatment 
effect. 
 
Prolactin, metoclopramide, milk lactose, milk yield 
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Abstract 
Objectives 
To investigate the effect of oral metoclopramide (MC) on serum prolactin (PRL) 
levels, on milk lactose, gross energy and dry matter during early lactation in healthy 
bitches. Milk lactose and puppy weight gain were determined to estimate treatment 
effect on milk production. 
Animals 
Twenty client-owned, healthy breeding bitches of various breeds and their 121 pups. 
Procedures 
Ten dogs received MC (0.2 mg/kg [0.09 mg/lb], per os, every 6 hours) for 6 days (T 
group) starting 10-24 hours after the birth of the last puppy (Day 0). Ten bitches 
served as controls (C group). Blood and milk samples from all bitches were collected 
on Day 0,1,2,4 and 6. Milk samples on Day 1 and 2, and on Day 4 and 6 were 
pooled due to small volume. Puppies were weighed twice daily. 
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Results 
Serum PRL increased significantly over time in both groups, and no treatment effect 
was seen. When the day-to-day change was analyzed with contrasts, PRL increased 
from Day 0 to Day 1 in the T (P = 0.050) but not in the C group. Milk lactose 
increased significantly during the study period and was higher in the T than in the C 
group. Milk dry matter was unchanged, while the time course of milk gross energy 
differed between treated and control dogs (P = 0.006). Puppy weight gain was not 
affected by MC treatment.  
Conclusions and Clinical Relevance 
In healthy bitches, the oral application of MC after parturition induced a transient 
serum PRL increase and stimulated milk lactose production. Especially dogs with 
insufficient or delayed milk production could benefit from this treatment effect. 
 
Abbreviations 
DM      Dry matter 
GE       Gross energy 
MC      Metoclopramide 
PRL     Prolactin 
PP        Postpartum 
 
 
Agalactia or hypogalactia in a PP bitch may pose serious risk to the health of 
the neonates. When puppies do not ingest sufficient amount of colostrum in the first 
16-24 hours after birth, failure of passive immune transfer occurs affecting their 
growth and survival.1,2 If neonates are not adequately nourished, they are at high risk 
of fading, becoming septic and may die soon after birth. Primary agalactia or 
hypogalactia is extremely rare and is associated with anatomical abnormalities of the 
mammary gland or a lack of response to physiological stimuli.3 In cases of 
secondary hypogalactia, milk production is decreased due to concurrent disease of 
the dam e.g. metritis, mastitis. Furthermore, hypocalcemia, stress (e.g. Cesarean 
section), premature delivery or undernourishment of the bitch may all lead to 
insufficient milk yield.3 Certain drugs or hormones, e.g. slow-release deslorelin 
implant or cabergoline, administered during pregnancy or lactation may also 
negatively influence milk production.4-6 
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Prolactin is essential for mammary gland development, initiation and 
maintenance of lactation.7-9 It is a polypeptide hormone produced by the lactotroph 
cells of the anterior pituitary.10 The most important regulator of PRL secretion is 
dopamine, which exerts a tonic inhibition from the hypothalamus.9 PRL secretion is 
stimulated by several substances and hormones, e.g. estradiol, thyrotrophin-
releasing hormone, ocytocin, vasoactive intestinal peptide, serotonin, opioid peptides 
or angiotensin II.9,11-13 In the bitch, substantial increases in serum PRL levels occur 
16-56 hours prepartum, reaching peak levels on the day of parturition, ~8-32 h 
before birth.14,15 After a decrease to near or below prepartum levels in the first 24-48 
h following delivery, PRL levels increase again to a secondary peak on Day 10 
PP.14,15 During lactation, high plasma PRL concentrations are present with large 
variations within and among individuals, 14,15 which may be partly due to the 
circadian rhythm of  PRL. 5 PRL stimulates α-lactalbumin production, 9,16,17 which is 
the regulatory subunit of the lactose synthase complex within the mammary 
gland.18,19 Lactose, through its osmotic actions, is the major determinant of the 
aqueous phase and thus the volume of milk.20 Milk lactose increased in Beagle 
bitches from 3.47% at 7-9 days PP to 4.13% at 29-30 days PP, while none of the 
other milk constituents varied over time.21 Similarly, Macias Rostami et al.,22 and 
Adkins et al.,23 also showed lactose in canine milk rising in the first five days of 
lactation or until two weeks PP, respectively. 
Milk lactose concentration and milk volume increased significantly in mothers 
with PRL deficiency and with lactation insufficiency after administration of 
recombinant human PRL.24 Increased PRL levels and galactorrhoea are reported 
side effects of the administration of MC, which is an antidopaminergic 
gastrointestinal prokinetic used for the prevention and treatment of nausea and 
vomiting.25,26 Therefore, MC is used as a galactogogue in human medicine to 
increase milk production.27,28 In puerperal women with term or premature infants and 
with or without lactational insufficiency, daily doses of 30 or 45 mg MC significantly 
increased serum PRL and/or milk yield;29-34 the higher dose resulted in faster onset 
of effects.29 However, others reported that the same daily amount (30 mg MC) failed 
to augment milk production in women with premature newborns.35,36 In dogs, a single 
intravenous injection of 0.4 mg/kg [0.18 mg/lb] MC resulted in a significant, transient 
serum PRL increase in healthy, anestrous bitches,37 and in male Beagles, MC at 0.2 
mg/kg [0.09 mg/lb], per os, every 8 hours was able to significantly stimulate PRL 
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concentration from 4.5 ± 1.1 ng/ml to 6.5 ± 1.6 ng/ml.38 This shows that also in dogs, 
pituitary PRL secretion is  modulated by the administration of dopamine D2 receptor 
antagonists. Although the use of MC to treat agalactia/hypogalactia in bitches on the 
basis of its PRL-stimulating actions is anecdotal and lacking scientific evidence, 
there are various protocols recommending MC at dosages ranging from 0.1-0.2 
mg/kg [0.045-0.09 mg/lb] or 0.2-0.5 mg/kg [0.09-0.225 mg/lb] every 6-8 or 8-12 
hours,3,39-41 to 1-5 mg/kg [0.45-2.25 mg/lb], every 6-8 hours40 subcutaneously or 
orally. The clinical efficacy of these regimens however has not yet been confirmed in 
a controlled study. 
The effects of galactogogues on milk yield and maternal PRL levels are widely 
studied, but their influence on milk composition is still not well known. In mothers 
with full-term newborns, MC did not alter milk PRL and sodium concentration,34 and 
did not influence total fat, dry matter, fat-free dry matter and total nitrogen content, 
but promoted the shift from colostrum to mature milk.30 Domperidone, another 
antidopaminergic gastrointestinal prokinetic which is also used in human medicine as 
a galactogogue, increased yield, carbohydrate and calcium content of preterm 
human milk compared to placebo treatment.42 The influence of MC administration on 
milk composition in dogs has not yet been studied. 
Our objective was to investigate the effect of MC on serum prolactin levels, 
milk lactose and milk energy content during early lactation in bitches. Milk lactose 
and weight gain of the puppies were determined to estimate treatment effect on milk 
production. 
 
Materials and methods  
Animals—Over a 2-year period, 20 client-owned healthy bitches and their 
138 healthy pups were included in the study. Written consent for all dogs to 
participate in the study was obtained from the owners. The study was approved by 
the Cantonal Veterinary Office of Zurich (permit no. 09/2012). The bitches were 
assigned into two groups by alternating inclusion into treatment (T; n=10) or control 
(C; n=10) group at the time of parturition. Only dogs undergoing natural birth and in 
good clinical condition throughout the study period were included. In the T group, 
there were 2 Boxers and one of each of the following breeds: Flatcoated Retriever, 
Labrador Retriever, Labradoodle, Tervueren, Great Dane, Leonberger, Border Collie, 
Rhodesian Ridgeback. The following dogs belonged to the C group: 4 Boxers, 2 
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Flatcoated Retrievers, 1 Golden Retriever, 1 German Shepherd, 1 Groenendael and 
1 Continental bulldog. During the study, the bitches with their puppies were kept by 
their owners in their normal environment. 
 
Treatment—Bitches in the T group received 0.2 mg/kg [0.09 mg/lb] MC as an 
oral suspensiona every 6 hours for 6 days after parturition. Treatment started 
between 10 to 24 hours after the birth of the last puppy (Day 0), immediately after 
the collection of the first blood and milk samples. None of the bitches in this study (T 
and C groups) received any other medication. 
 
Blood and milk sample collection—The start of the study was defined as 
Day 0, between 10-24 hours after the birth of the last puppy in a litter. Blood samples 
(4-5 mL) were collected from the jugular vein into a serum tube on Day 0, 1, 2, 4 and 
Day 6, twice each day, 30 minutes apart, to account for the pulsatile release of 
PRL.43,44 Because peripheral PRL levels in early lactating bitches may also show a 
circadian rhythm,5 in each individual bitch, blood samples were collected always at 
the same time of the day, i.e. morning, afternoon or evening. Cooled blood samples 
were transported to the clinic and centrifuged for 10 minutes at 3’000 g. Serum was 
harvested and stored at -80°C until analysis. At the same time of blood sampling, 1-2 
mL of milk taken from several glands of each bitch was collected. Day 0 blood and 
milk samples in the T group were taken before starting the MC treatment. Clinical 
examinations were carried out by the same veterinarian on each sampling day. 
Palpation of the mammary glands and macroscopic evaluation of the milk were used 
to detect early signs for mastitis and to estimate milk yield. 
  
Determination of serum prolactin levels—Serum PRL concentration was 
analyzed with a previously validated heterologous radioimmunoassay.45 All samples 
were run in one batch. The intra-assay coefficient of variation was 3.5%, and the 
lower limit of detection was 0.8 ng/ml. 
 
Determination of milk composition and gross energy—Milk samples 
before treatment (Day 0) and after the start of treatment (Day 1-6) were analyzed. 
Due to insufficient amount of milk on individual days, milk from Day 1 and 2, and 
from Day 4 and 6 was pooled for the measurements. Defrosted milk was analyzed 
8 
 
for GE using an anisothermal bomb calorimeterb, and expressed on DM basis 
(GE/DM; J/g DM). The DM content of milk (%) was determined by drying of 0.1-0.4 g 
milk at 103°C up to weight constancy. Milk lactose content was determined using a 
modification of the method previously described.22 Briefly, whole milk was dissolved 
1:1000 (g/g) in distilled water, passed through a 0.22 μm membrane filter to remove 
particles and transferred to a 2mL autosampler vial. An aliquot (25 μL) was analyzed 
on a high performance anion exchange liquid chromatograph equipped with a pulsed 
amperometric detectorc using a Carbopac PA1 column (4 × 250 mm, Thermo) held 
at 25 ºC. Lactose was eluted at 1.0 ml/min using a sodium hydroxide/sodium acetate 
gradient as follows: 0 min, 50 mM NaOH; 2 min, 50 mM NaOH; 18 min, 135 mM 
NaOH; 18.1 min, 140 mM NaOH + 7.5 mM sodium acetate; 25 min, 140 mM NaOH + 
7.5 mM sodium acetate; 35 min, 142.5 mM NaOH + 12.5 mM sodium acetate; 35.1 
min, 189 mM NaOH + 90 mM sodium acetate; 45 min, 210 mM NaOH + 100 mM 
sodium acetate; 45.1 min, 300 mM NaOH + 250 mM sodium acetate; 50 min, 300 
mM NaOH + 250 mM sodium acetate; 50.1 min, 50 mM NaOH; 60 min, 50 mM 
NaOH. Under these conditions lactose has a retention time of approximately 12.5 
min. Detection was performed by pulsed amperometry using a gold working 
electrode and a standard quadruple waveform for carbohydrates (t= 0 s, V=+0.1 V; t 
= 0.2 s, V=+0.1 V; t= 0.4 s, V= +0.1 V; t= 0.41 s, V= -2.0 V; t= 0.42 s, V= -2.0 V; t = 
0.43 s, V=+0.6 V; t= 0.44 s, V= -0.1 V; t =0.50 s, V=-0.1 V). Quantification was 
performed using an external calibration curve. Lactose content was also expressed 
on DM milk (Lactose/DM, g/kg). 
  
Puppy weight gain—Body weight of each puppy was recorded by the owners 
immediately after parturition and twice daily thereafter (morning and evening) during 
the study period. 
 
Statistical analysis—Age, body weight, body condition score, litter size (live 
pups) and parity (no. of current pregnancy) of the bitches on Day 0 was compared 
between the T and C groups by independent samples T-test and Mann-Whitney U 
test. The mean of the two serum PRL concentrations, which were collected 30 min. 
apart from each animal on a given day, was used for the statistical calculations. The 
change in PRL serum levels over time and the effect of treatment, the bitches’ age, 
body weight, parity (primi- or pluriparous) and litter size was analyzed with mixed 
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models. The day-to-day change of serum PRL concentration in the C and T groups 
was compared using contrast in the mixed model. Milk composition and milk gross 
energy were analyzed with a mixed model, and included treatment, the bitches’ age, 
body weight, parity and litter size as independent variables. Because puppy weight 
recordings on the last study day (Day 6) were not complete, we chose the evening 
weight on Day 5 as endpoint. The change in puppy weights was therefore analyzed 
between Day 0 and Day 5 with a mixed model using the bitch as a random factor, 
and treatment, the bitches’ weight, parity, litter size and initial weight of the pups as 
independent variables. Data was analyzed with computerized statistical programsd,e. 
Significance was set at P ≤ 0.050. 
 
Results 
Animals—The T and C groups were similar in terms of age, body weight, 
body condition score and litter size (Table 1). There were four and two primiparous, 
and six and eight pluriparous animals among the T and C bitches, respectively. 
Current pregnancy number was also not different between the groups (Table 1). 
 
Table 1—General description of the bitches in the control group (n=10) and in the 
metoclopramide treatment group (n=10) at the start of the study (Day 0*). 
Groups Age (years) Body weight (kg; lbs) BCS‡  
Litter size (live 
pups) 
Current 
pregnancy 
number 
Treatment 
(n=10) 
4.4 ± 1.8 
31.6 ± 12.9; 
69.6 ± 28.4 
4.7 ± 0.8 
(n=9) 
6.9 ± 1.9 2.2 ± 1.4 
Control 
(n=10) 
4.3 ± 1.7 
27.7 ± 4.9; 
61.0 ± 10.8 
4.3 ± 0.5 
(n=9) 
6.9 ± 2.4 2.3 ± 1.2 
P value† 0.823 0.580 0.247 1.000 0.684 
Values represent the mean ± SD. *Day 0: 10-24 hours after the birth of the last 
puppy. †P value ≤ 0.050 within a column denotes statistical difference between the 
treatment and control groups. ‡BCS: body condition score (on a 9-point scale 
system,46). 
 
Serum PRL concentrations—PRL concentration of the 20 bitches at the time 
of whelping was 26.27 ± 10.1 ng/mL (mean ± SD), and increased significantly over 
time in both groups from Day 0 to Day 6 (P = 0.032 in C, and P = 0.041 in T;     
Figure 1).  
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Figure 1—Serum PRL concentrations in the control (n=10) and treatment group 
(n=10) from Day 0 (after parturition and before the start of treatment) to Day 6 of the 
study. Treated bitches received MC at 0.2 mg/kg [0.09 mg/lb], per os, every 6 hours, 
for 6 days.  
 
No effect of treatment on PRL levels was shown in the mixed model (P = 
0.087). When the day-to-day change was separately analyzed with contrasts, serum 
PRL concentrations increased significantly from Day 0 to Day 1 in the T group (P = 
0.050), but not in the C group (P = 0.998) (Figure 2).  
 
Figure 2—Change in serum PRL concentration from Day 0 (after parturition and 
before the start of treatment) to Day 1 in the bitches of the control (n=10) and 
treatment (n=10) group. Treated bitches received MC at 0.2 mg/kg [0.09 mg/lb], per 
os, every 6 hours, for 6 days. 
 
There was no difference between the groups in the day-to-day change of 
serum PRL later on (P ≥ 0.171). The bitches’ age, body weight, parity and litter size 
did not influence serum PRL values (P ≥ 0.137). The lowest (8.56 ng/mL) and 
highest (55.54 ng/mL) PRL concentrations on Day 0 (before the start of treatment) 
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were found in a Groenendael bitch and in a Rhodesian Ridgeback, respectively. PRL 
levels in this Ridgeback belonging to the T group were always the highest (55.54-
87.43 ng/mL), and in the Groenendael belonging to the C group almost always the 
lowest (8.12-10.00 ng/mL) of all bitches during the whole study period. 
 
Milk composition—Milk DM content did not significantly change over time 
(P=0.287), and did not differ between the T and C group (P=0.156) (Figure 3). 
 
Figure 3—Milk DM (%) in the control (n=10) and MC-treated bitches (n=10) in 
samples collected on Day 0 (after parturition and before the start of treatment), and 
in samples pooled from Day 1 and 2, and from Day 4 and 6. 
 
Milk lactose content and Lactose/DM increased significantly over time (P<0.0001). 
Treated bitches had higher lactose content in milk, both as lactose (g) per kg whole 
milk (Figure 4A) and as Lactose/DM (Figure 4B) compared to C dogs (P = 0.035 and 
P = 0.004, respectively).  
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Figure 4—A: Milk lactose content (g/kg whole milk) and B: Lactose/DM (g/kg) in the 
control (n=10) and MC-treated bitches (n=10) in milk samples collected on Day 0 
(after parturition and before the start of treatment), and in samples pooled from Day 
1 and 2, and from Day 4 and 6.  
 
Pluriparous bitches had lower milk lactose content (P=0.034) and Lactose/DM 
(P=0.016) than primiparous dogs.  The time course of GE/DM differed significantly 
between the T and C group (P = 0.006). While in the C animals GE/DM increased 
steadily, in the T group, after a higher increase from Day 0 to Day 1+2, it decreased 
by Day 4+6 reaching similar values to the C group (Figure 5). Litter size was 
inversely related to milk GE/DM (P = 0.016). 
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Figure 5—Milk GE expressed on DM basis (J/g DM) in the control (n=10) and MC-
treated bitches (n=10) in milk samples collected on Day 0 (after parturition and 
before the start of treatment), and in samples pooled from Day 1 and 2, and from 
Day 4 and 6.  
 
  
Puppy weight gain—The bitches gave birth to a total of 147 puppies, of 
which 138 were alive at birth and 9 were stillborn. Further two puppies in the C group 
died during the study period, and two puppies from the T group were excluded 
because they were fed with milk replacer. Puppy weights (n=13) were not available 
from two bitches in the T group, and information on neonatal losses during the study 
was available from only one of them. Overall, data of 121 pups (67 from the C 
bitches and 54 from the T bitches) were analyzed. 
Heavier puppies as well as puppies of heavier bitches gained significantly more 
weight than smaller pups (Figure 6) or those of smaller dams (P=0.0002 and 
P=0.032, respectively).  
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Figure 6—Weight gain of the puppies (n=67 of the control bitches, n=54 of the MC-
treated bitches) during the study period (between Day 0 and Day 5) in relation to 
their starting weight on Day 0. 
 
 
Litter size seemed to have an inverse relationship with pup weight gain (P=0.055), 
while parity of the dam had no influence (P=0.792). Treatment did neither affect 
weight gain of the puppies (P=0.665; Figure 6) nor had any obvious effects on health 
status or behavior. 
 
Discussion 
Despite recommendations in the literature,3,39,40 the clinical efficacy of the 
dopamine D2 receptor antagonist MC as a galactogogue has not been evaluated in 
a controlled study in dogs.  The opposite effect of the dopamine D2 receptor agonist 
cabergoline, i.e. the suppression of PRL secretion and the reduction of milk 
production in lactating bitches has been known for decades.5,6 The successful 
application of domperidone, another dopamine D2 receptor antagonist, was only 
recently described as a case report in a queen with agalactia.47 To estimate the 
effect of MC on milk production, we measured serum prolactin levels, milk lactose, 
milk energy and puppy weight gain. Over the study period, PRL levels were 
increasing and reached the highest values in the end of the study, which is in 
agreement with the results of previous reports.14,15 Interestingly, the known serum 
PRL decline of the first 24-48 hours after whelping was seen in most C bitches, while 
it only occurred in two bitches of the T group. We assume that the administration of 
MC prevented this initial decrease in serum PRL. This finding would fit to our 
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hypothesis of MC increasing PRL secretion. From a practical point of view, it would 
be of great benefit, if the MC-induced PRL increase resulted in increased colostrum 
production. The most important phase of colostrum intake for the pups is in the first 
four hours after birth,2 however, this critical time window could not be covered by our 
study design. Although this initial PRL increase was seen only in the MC-treated 
dogs, PRL levels did not differ between the groups later on. The large variation of 
serum PRL, which was apparent already before treatment and throughout the study, 
may have masked the effect of treatment in this small number of dogs. This finding is 
in agreement with the report of Onclin and Verstegen,15 who also studied the course 
of PRL concentration in nursing bitches, and assumed that the high variability was 
caused by the effect of suckling of the pups. Indeed, nursing of the young has been 
shown to directly stimulate PRL release from the anterior pituitary in several 
species.48,49 In rodent studies, the PRL rise in response to nursing has been shown 
by its positive correlation with litter size, i.e. intensity of the suckling stimulus.50,51 
Although we could have minimized the effect of suckling by separating the pups from 
the bitches before blood collection, this would have interfered with the goal of the 
owners to not disturb pup-bitch bonding. We still attempted to diminish possible 
physiological PRL variations43,44 by collecting blood twice, 30 min. apart, and 
calculating the mean of the two values. To account for the possible circadian rhythm 
of PRL, which was shown in lactating Beagle bitches,5 we always collected the blood 
samples in each individual bitch at the same time of the day.  However, nursing of 
the pups in some of the bitches during blood collection as well as a possible 
circadian variation most likely contributed to the high variability of our PRL data, 
thereby masking an MC-effect. The same may be true for litter size, which, in 
contrast to previous reports,50,51 was not recognized as an influencing factor in our 
study. However, according to studies in women,32 continuous oral MC administration 
eliminate the substantial PRL rise in response to suckling. If this were true in dogs at 
the low dosage used in our study, nursing would have influenced serum PRL 
variability only in the C group, but it would have had no or perhaps minimal influence 
in the T group. However, due to the study design with client-owned dogs, this was 
not investigated. Furthermore, individual and/or breed differences in serum PRL 
concentration may exist as shown for German shepherds having lower PRL levels 
than Beagles during the luteal phase.52 Although investigating breed variations was 
not in the scope of our study, it is interesting to note that a Rhodesian Ridgeback 
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bitch in the T group had PRL levels twice as high as all the other dogs before and 
after treatment.    
Besides PRL as an indirect estimate of milk production, we also measured 
more direct variables in the milk like lactose, which is known to increase the aqueous 
phase of milk and thus volume through its osmotic actions.20 Similarly to the results 
of previous reports,21-23 milk lactose levels (on whole milk and on DM basis) 
increased significantly over time in our study. Because this increase in milk lactose 
content after parturition seems to coincide with increasing milk yield in the dog53 as 
well as in women and in cows,54,55 the steeper increase of milk lactose levels in the T 
group may be associated with increased milk production. Determination of milk 
osmolality could have added more information on the physiological changes during 
lactation as well as on the pharmaceutical effects of MC, and will be included in a 
future study. Besides lactose content, we also assessed the effect of MC on milk 
quality by measuring DM and GE/DM. DM content in the milk was not affected by 
time or by treatment, but GE/DM was increasing. This increase was noted over time, 
and interestingly, occurred earlier in the T group. These findings together with 
increasing Lactose/DM indicate that milk composition was not only changing over 
time, but that these changes might be initiated earlier by MC treatment. The effects 
of MC on milk quality implicate that this treatment may increase milk production 
earlier, which could be of great benefit for hypogalactic bitches. Still, it should be 
kept in mind that the number of dogs included in our study was small, the measured 
values were highly variable, and the amount of milk samples was limited. It would 
have been worth to evaluate milk composition in more details and to start one day 
before parturition. This would have allowed us to determine whether MC promoted 
the shift from colostrum to mature milk based on amino acid profile in the bitch, as it 
does in healthy puerperal women.30 However, such a study design would have 
required laboratory dogs, as it is not feasible with client-owned animals. 
Although our results on serum PRL and milk composition seem to support the 
positive influence of MC on milk yield, these measurements cannot substitute the 
determination of milk output. In women, either emptying the breast by pumping or 
weighing the infants before and after nursing is used to assess milk production.29-32 
However, emptying all the glands in a dog is not possible. Weighing all the puppies 
in the litter before and after nursing was included in our study design, but it could not 
be carried out because of lack of owner compliance. We still recorded all puppy 
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weights twice daily, and analysed their growth pattern as an indirect measure of the 
amount of milk produced by the bitch. Pup weight gain was negatively influenced by 
litter size, which is also known from rats.56 This can be explained by the reduced 
energy content of the milk in bitches carrying larger litters. Surprisingly, pluriparous 
dogs had similar milk DM as primiparous bitches, but lower lactose concentration in 
milk and Lactose/DM. This does not fit to our clinical experience that pluriparous 
bitches initiate lactation earlier, and therefore to our expectations of a higher milk 
lactose content. However, the weight gain of the pups in the two parity groups was 
similar. We could not show any effect of treatment on pup weight gain, which is not 
surprising, as treated and control bitches were healthy and without clinical signs of 
hypogalactia. To prove the positive effect of maternal MC treatment on weight gain, 
development and health of puppies of hypogalactic bitches, a study with affected 
dams would be needed. However, to have a control hypogalactia group, which 
means neither treating the mothers with MC nor supplementing the pups that are not 
thriving with milk replacer, is not ethical.  
The dose of MC used in our study (0.2 mg/kg [0.09 mg/lb], per os, every 6 
hours) corresponds to the recommendations in the literature ranging from 0.1-0.5 
mg/kg [0.045-0.225 mg/lb] every 6-12 hours3,39-41 to 1-5 mg/kg [0.45-2.25 mg/lb] 
every 6-8 hours.40 The safety of drugs which are not approved for the given 
indication is always a concern, as it was the case in our study using MC to increase 
milk production in lactating bitches. In the Plumb’s Veterinary Drug Handbook26 MC 
is described for the promotion of milk production in dogs at a dose of 0.1–0.2 mg/kg 
[0.045-0.09 mg/lb], subcutaneously, every 12 hours, without mentioning apparent 
risk to the nursing offspring. Even though the European Medicines Agency limits the 
direct application of MC to children, the most commonly reported adverse effects 
(e.g. extrapyramidal symptoms, diarrhea, sedation) in a recent systematic review 
and meta-analysis on MC safety in children were reversible and had no long-term 
significance.57 In nursing mothers, the use of MC as a galactogogue was 
recommended, however due to side effects (e.g. headache, diarrhea), domperidone, 
which does not cross the blood–brain barrier as readily as MC, was recently 
proposed as a safer alternative.33 After the start of our study, domperidone has been 
recommended as a galactogogue in dogs40 and might be a good or even better 
alternative to MC, although its clinical efficacy is not confirmed in a controlled study.  
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In conclusion, in healthy bitches, the oral application of MC at a dose of 0.2 
mg/kg [0.09 mg/lb] every 6 hours for 6 days starting immediately after parturition, 
induced a significant serum PRL increase from day 0 to day 1, and enhanced milk 
lactose production. Especially dogs with insufficient or delayed milk production could 
benefit from this effect. 
 
 
Footnotes 
aPaspertin®, BGP Products GmbH, Baar, Switzerland 
bIKA calorimeter C2000 Basic, IKA-Werke GmbH, Staufen, Germany 
cHPAEC-PAD, ICS3000, Thermo Fischer Dionex, Sunnyvale, CA 
dIBM® SPSS® Statistics for Windows, Version 22.0, Armonk, NY 
eR Core Team (2016). R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
References  
1. Mila H, Feugier A, Grellet A, et al. Inadequate passive immune transfer in 
puppies: definition, risk factors and prevention in a large multi-breed kennel. 
Prev Vet Med 2014;116:209-213. 
2. Chastant-Maillard S, Freyburger L, Marcheteau E, et al. Timing of the 
intestinal barrier closure in puppies. Reprod Domest Anim 2012;47 Suppl 
6:190-193. 
3. Marti JA, Fernandez S. Clinical approach to mammary gland disease. In: 
England G,von Heimendahl A, eds. BSAVA Manual of canine and feline 
reproduction and neonatology Gloucester, UK: British Small Animal Veterinary 
Association, 2010;155-165. 
4. Goericke-Pesch S, Georgiev P, Atanasov A, et al. Treatment with Suprelorin 
in a pregnant cat. Journal of feline medicine and surgery 2013;15:357-360. 
5. Romagnoli S, Milani C, Perin S, et al. Effect of an injectable cabergoline 
formulation on serum prolactin (PRL) and milk secretion in early postpartum 
Beagle bitches. Reprod Domest Anim 2009;44 Suppl 2:148-151. 
6. Jochle W, Ballabio R, di Salle E. Inhibition of lactation in the Beagle bitch with 
the prolactin inhibitor cabergoline (FCE 21336): Dose response and aspects 
of long-term safety. Theriogenology 1987;27:799-810. 
7. Jöchle W. Prolactin in Canine and Feline Reproduction. Reprod Domest Anim 
1997;32:183-193. 
8. Ostrom KM. A review of the hormone prolactin during lactation. Prog Food 
Nutr Sci 1990;14:1-43. 
9. Crowley WR. Neuroendocrine regulation of lactation and milk production. 
Compr Physiol 2015;5:255-291. 
10. Freeman ME, Kanyicska B, Lerant A, et al. Prolactin: structure, function, and 
regulation of secretion. Physiol Rev 2000;80:1523-1631. 
11. Lamberts SW, Macleod RM. Regulation of prolactin secretion at the level of 
the lactotroph. Physiol Rev 1990;70:279-318. 
12. Koch A, Hoppen HO, Dieleman SJ, et al. Effects of the dopamine agonist 
cabergoline on the pulsatile and TRH-induced secretion of prolactin, LH, and 
testosterone in male beagle dogs. Theriogenology 2006;65:1666-1677. 
13. Leong DA, Frawley LS, Neill JD. Neuroendocrine control of prolactin 
secretion. Annu Rev Physiol 1983;45:109-127. 
20 
 
14. Concannon PW, Butler WR, Hansel W, et al. Parturition and lactation in the 
bitch: serum progesterone, cortisol and prolactin. Biol Reprod 1978;19:1113-
1118. 
15. Onclin K, Verstegen JP. Secretion patterns of plasma prolactin and 
progesterone in pregnant compared with nonpregnant dioestrous beagle 
bitches. J Reprod Fertil Suppl 1997;51:203-208. 
16. Turkington RW, Brew K, Vanaman TC, et al. The hormonal control of lactose 
synthetase in the developing mouse mammary gland. J Biol Chem 
1968;243:3382-3387. 
17. Turkington RW, Hill RL. Lactose synthetase: progesterone inhibition of the 
induction of alpha-lactalbumin. Science 1969;163:1458-1460. 
18. Kuhn NJ, Carrick DT, Wilde CJ. Lactose synthesis: the possibilities of 
regulation. J Dairy Sci 1980;63:328-336. 
19. Ramakrishnan B, Qasba PK. Crystal structure of lactose synthase reveals a 
large conformational change in its catalytic component, the beta1,4-
galactosyltransferase-I. J Mol Biol 2001;310:205-218. 
20. Holt C. Swelling of Golgi vesicles in mammary secretory cells and its relation 
to the yield and quantitative composition of milk. J Theor Biol 1983;101:247-
261. 
21. Oftedal OT. Lactation in the dog: milk composition and intake by puppies. J 
Nutr 1984;114:803-812. 
22. Macias Rostami S, Benet T, Spears J, et al. Milk oligosaccharides over time of 
lactation from different dog breeds. PLoS One 2014;9:e99824. 
23. Adkins Y, Lepine AJ, Lonnerdal B. Changes in protein and nutrient 
composition of milk throughout lactation in dogs. Am J Vet Res 2001;62:1266-
1272. 
24. Powe CE, Allen M, Puopolo KM, et al. Recombinant human prolactin for the 
treatment of lactation insufficiency. Clin Endocrinol (Oxf) 2010;73:645-653. 
25. Tonini M, Cipollina L, Poluzzi E, et al. Review article: clinical implications of 
enteric and central D2 receptor blockade by antidopaminergic gastrointestinal 
prokinetics. Aliment Pharmacol Ther 2004;19:379-390. 
26. Plumb DC. Plumb's veterinary drug handbook. 7th ed. Ames, Iowa, USA: 
Wiley-Blackwell, 2011. 
21 
 
27. Gabay MP. Galactogogues: medications that induce lactation. J Hum Lact 
2002;18:274-279. 
28. Zuppa AA, Sindico P, Orchi C, et al. Safety and efficacy of galactogogues: 
substances that induce, maintain and increase breast milk production. J 
Pharm Pharm Sci 2010;13:162-174. 
29. Kauppila A, Kivinen S, Ylikorkala O. A dose response relation between 
improved lactation and metoclopramide. Lancet 1981;1:1175-1177. 
30. de Gezelle H, Ooghe W, Thiery M, et al. Metoclopramide and breast milk. Eur 
J Obstet Gynecol Reprod Biol 1983;15:31-36. 
31. Kauppila A, Anunti P, Kivinen S, et al. Metoclopramide and breast feeding: 
efficacy and anterior pituitary responses of the mother and the child. Eur J 
Obstet Gynecol Reprod Biol 1985;19:19-22. 
32. Ehrenkranz RA, Ackerman BA. Metoclopramide effect on faltering milk 
production by mothers of premature infants. Pediatrics 1986;78:614-620. 
33. Ingram J, Taylor H, Churchill C, et al. Metoclopramide or domperidone for 
increasing maternal breast milk output: a randomised controlled trial. Arch Dis 
Child Fetal Neonatal Ed 2012;97:F241-245. 
34. Ertl T, Sulyok E, Ezer E, et al. The influence of metoclopramide on the 
composition of human breast milk. Acta Paediatr Hung 1991;31:415-422. 
35. Fife S, Gill P, Hopkins M, et al. Metoclopramide to augment lactation, does it 
work? A randomized trial. J Matern Fetal Neonatal Med 2011;24:1317-1320. 
36. Hansen WF, McAndrew S, Harris K, et al. Metoclopramide effect on 
breastfeeding the preterm infant: a randomized trial. Obstet Gynecol 
2005;105:383-389. 
37. Kolster K. A., Panciera D. L., Purswell B. J., et al. Control of prolactin 
secretion in canine hypothyroidism. Clinical Theriogenology 2010;2:185-190. 
38. Koivisto MB, Eschricht F, Urhausen C, et al. Effects of short-term hyper- and 
hypoprolactinaemia on hormones of the pituitary, gonad and -thyroid axis and 
on semen quality in male Beagles. Reprod Domest Anim 2009;44 Suppl 
2:320-325. 
39. Davidson AP. Reproductive disorders in the dog and bitch with genetic 
concerns. Proceedings of the Voorjarsdagen Veterinary Conference 
2007:157-161. 
22 
 
40. Romagnoli S., Lopate C. Control of mammary gland function in the bitch and 
queen: a review. Clinical Theriogenology 2012;4:196-205. 
41. Peterson ME, Kutzler MA. Small animal pediatrics: the first 12 months of life. 1 
ed. St. Louis, Missouri: Elsevier Saunders, 2011. 
42. Campbell-Yeo ML, Allen AC, Joseph KS, et al. Effect of domperidone on the 
composition of preterm human breast milk. Pediatrics 2010;125:e107-114. 
43. Gobello C, Bolognani F, de la Sota RL, et al. Twenty-four-hour profiles of 
serum prolactin and luteinizing hormone in anoestrous crossbred bitches. 
Reprod Domest Anim 2001;36:41-45. 
44. Corrada Y, Castex G, Sosa Y, et al. Secretory patterns of prolactin in dogs: 
circannual and ultradian rhythms. Reprod Domest Anim 2003;38:219-223. 
45. Okkens AC, Dieleman SJ, Bevers MM, et al. Evidence for the non-
involvement of the uterus in the lifespan of the corpus luteum in the cyclic dog. 
Vet Q 1985;7:169-173. 
46. Fascetti AJ, Delaney SJ. Applied veterinary clinical nutrition. 1st ed. 
Chichester, UK: Wiley-Blackwell, 2012. 
47. Jensen R.L., Johnson A.K., Wilborn R.R., et al. A case report on the use of 
domperidone for management of agalactia in a queen. Clinical 
Theriogenology 2016;8:121-126. 
48. Frawley LS, Mulchahey JJ, Neill JD. Nursing induces a biphasic release of 
prolactin in rhesus monkeys. Endocrinology 1983;112:558-561. 
49. Jonas W, Woodside B. Physiological mechanisms, behavioral and 
psychological factors influencing the transfer of milk from mothers to their 
young. Horm Behav 2016;77:167-181. 
50. Mattheij JA, Swarts HJ, Verstijnen CP. The response of plasma prolactin to 
suckling during normal and prolonged lactation in the rat. Horm Res 
1984;20:261-268. 
51. Mattheij JA, Gruisen EF, Swarts JJ. The suckling-induced rise of plasma 
prolactin in lactating rats: its dependence on stage of lactation and litter size. 
Horm Res 1979;11:325-336. 
52. Gunzel-Apel AR, Beste N, Nottorf S, et al. Comparison of selected endocrine 
parameters during luteal phase and pregnancy in German Shepherd dogs and 
Beagles. Reprod Domest Anim 2009;44 Suppl 2:59-64. 
23 
 
53. Bostedt H. Erkrankungen des Gesäuges/Diseases of the mammary gland (in 
German) In: Günzel-Apel AR,Bostedt H, eds. Reproduktionsmedizin und 
Neonatologie von Hund und Katze. 1st ed. Stuttgart, Germany: Schattauer, 
2016;218. 
54. Saint L, Smith M, Hartmann PE. The yield and nutrient content of colostrum 
and milk of women from giving birth to 1 month post-partum. Br J Nutr 
1984;52:87-95. 
55. Hartmann PE. Changes in the composition and yield of the mammary 
secretion of cows during the initiation of lactation. J Endocrinol 1973;59:231-
247. 
56. Chahoud I, Paumgartten FJ. Influence of litter size on the postnatal growth of 
rat pups: is there a rationale for litter-size standardization in toxicity studies? 
Environ Res 2009;109:1021-1027. 
57. Lau Moon Lin M, Robinson PD, Flank J, et al. The Safety of Metoclopramide 
in Children: A Systematic Review and Meta-Analysis. Drug Saf 2016;39:675-
687. 
 
 
 
24 
 
Danksagung 
An dieser Stelle möchte ich mich herzlichst bei allen bedanken, die zum Gelingen  
meiner Dissertation beigetragen haben.  
Besonderen Dank gilt meiner Betreuerin Orsolya Balogh, welche sehr viel Zeit in die 
Arbeit investiert hat, immer wieder neue Ansätze einbrachte, sowie mir immer die 
Möglichkeit gab mich und meine eigenen Ideen einzubringen. Sie hat massgebend 
zum Erfolg dieser Arbeit beigetragen wofür ich ihr sehr dankbar bin.   
Des Weiteren möchte ich mich bei Prof. Dr. I.M. Reichler herzlichst bedanken für die 
Betreuung der Arbeit, das Vetrauen, welches sie mir auch im Bereich der klinischen 
Arbeit entgegen bringt, sowie der enormen Unterstützung meines beruflichen 
Werdegangs.  
Ohne die Mitarbeit aller Züchter und ihrer sehr kooperativen Hündinnen wäre diese 
Arbeit nie entstanden. Auf diesem Weg möchte ich mich bei allen Züchtern und ihren 
Hunden bedanken für ihr Vertrauen, ihre Zeit, Geduld und das Interesse an meiner 
Dissertation.  
Das Team in welchem ich in dieser Zeit arbeiten durfte, hat mich stets unterstützt 
und motiviert. Wir haben im Arbeitsalltag sowie auch in der Freizeit viele 
unvergessliche, lustige und teils auch schwierige Momente durchlebt. Ich möchte 
mich dafür bei allen ganz herzlich bedanken.  
Ich möchte mich an dieser Stelle auch ganz herzlich bei meiner Mutter bedanken, 
welche mir diesen Weg überhaupt ermöglicht hat, mich stets unterstützt und mir 
bereits  mein ganzes Leben mit Rat und Tat zur Seite steht.  
Wenn mich die Arbeit gedanklich in der Freizeit beschäftigt hat, waren immer liebe 
Freunde an meiner Seite, welche mit Halt gaben und mir immer wieder neue Wege 
aufgezeigt haben. Vielen Dank! 
Zum Schluss gilt mein Dank auch meiner ständigen Begleiterin, Ronja. Wir wären 
uns vielleicht ohne diese Doktorarbeit nie begegnet. Sie hat mich die meiste Zeit 
begleitet, mir viel Freude bereitet und abends immer geduldig auf mich gewartet. 
 
     
25 
 
Lebenslauf 
Vorname Name Stefanie  Rahel Keller 
Geburtsdatum 13.04.1986 
Geburtsort Aarau 
Nationalität Schweizerin 
Heimatort bei 
Schweizern 
5722 Gränichen 
08/2001– 06/2005 Kantonsschule (Neue Kantonsschule Aarau, Aarau, 
Schweiz) 
  
24.06.2009 Kantonale Maturität (Neue Kantonsschule Aarau, 
Aarau, Schweiz)  
  
08/2006 – 10/2011 Veterinärmedizin (Schwerpunkt Kleintiere, Vetsuisse 
Fakultät, Zürich, Schweiz) 
  
17.10.2011 Abschlussprüfung vet. med. (Vetsuisse-Fakultät 
Universität Zürich, Zürich, Schweiz) 
  
11/2011 – 05/2017 Anfertigung der Dissertation  
   unter Leitung von Prof. Dr. I. M. Reichler 
 am Departement für Nutztiere, Klinik für 
Reproduktionsmedizin  
 der Vetsuisse-Fakultät, Universität Zürich 
Direktor: Prof. Dr. Heiner Bollwein 
  
11/2011 – 02/2014 Assistenzärztin/Doktorandin, Klinik für 
Reproduktionsmedizin, Vetsuisse-Fakultät Universität 
Zürich, Zürich, Schweiz 
03/2014 – 02/2015 Internship Kleintierreproduktion im Rahmen der 
FVH/Residency-Ausbildung, Tierspital Zürich, Zürich, 
Schweiz 
02/2015 –  Assistenzärztin/Doktorandin, Klinik für 
Reproduktionsmedizin, Vetsuisse-Fakultät Universität 
Zürich, Zürich, Schweiz 
 
 
 
 
